Profile
Eir Ventures is a life science venture capital firm focused on financing the development of innovative medicine. The firm has a seasoned investment team of 6 members, including 5 PhDs and 3 MDs, with a balanced gender representation of 50% female and male. Eir Ventures differentiates itself through its active ownership model, which includes company creation and board involvement, aiming to drive portfolio progress and deliver high returns to investors.
Eir Ventures invests primarily in the life sciences sector, targeting companies with transformative potential, excellence in execution, and scalability. The firm has made a total of 20 investments, including 12 clinical programs and 4 products that have received marketing approval. Their investment strategy is supported by a network of 38 international syndication partners and includes a focus on Nordic innovation to enhance global health.
Notable investments include 11 company creations, 3 IPOs, and various collaborations with pharmaceutical companies. Eir Ventures is committed to improving millions of lives through its investments and actively participates in the governance of its portfolio companies, holding 11 board seats and several leadership roles.
Industry
Contacts
Instant access on the web. Plans from $129/month — see pricing.